I agree that this site is using cookies. You can find further informations here.
X
Slob, G.L.
100  results:
Search for persons X
?
1

Malnutrition in critically ill patients with COVID-19 and i..:

Maffini, L.F. ; de Paula, J.A. ; Dantas, D....
Clinical Nutrition ESPEN.  58 (2023)  - p. 592-593 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Prevalence of myopenia and myosteatosis in critically ill p..:

Slob, G.L. ; da Silva, C.R. ; Baumgartner, R....
Clinical Nutrition ESPEN.  58 (2023)  - p. 592 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Low calf circumference is associated with prolonged mechani..:

Slob, G.L. ; Leite, L.S. ; de Paula, J.A....
Clinical Nutrition ESPEN.  58 (2023)  - p. 593 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Quality of life related to oral health and its impact in ad..:

Spanemberg, J.C. ; Cardoso, J.A. ; Slob, E.M.G.B..
Journal of Stomatology, Oral and Maxillofacial Surgery.  120 (2019)  3 - p. 234-239 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Age and metal gradients in massive quiescent galaxies at 0...:

Cheng, Chloe M ; Kriek, Mariska ; Beverage, Aliza G...
Monthly Notices of the Royal Astronomical Society.  532 (2024)  3 - p. 3604-3623 , 2024
Link: https://doi.org/10.1093/..
 
?
6

A Method for Comparing the Impact on Carcinogenicity of Tob..:

Slob, Wout ; Soeteman‐Hernández, Lya G. ; Bil, Wieneke...
Risk Analysis.  40 (2020)  7 - p. 1355-1366 , 2020
Link: https://doi.org/10.1111/..
 
?
7

Evaluating the evidence for non-monotonic dose-response rel..:

Varret, C. ; Beronius, A. ; Bodin, L....
Toxicology and Applied Pharmacology.  339 (2018)  - p. 10-23 , 2018
Link: https://doi.org/10.1016/..
 
?
8

APROBA-Plus: A probabilistic tool to evaluate and express u..:

Bokkers, Bas G.H. ; Mengelers, Marcel J. ; Bakker, Martine I...
Food and Chemical Toxicology.  110 (2017)  - p. 408-417 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Review of non‐monotonic dose‐responses of substances for hu..:

Beausoleil, C. ; Beronius, A. ; Bodin, L....
EFSA Supporting Publications.  13 (2016)  5 - p. , 2016
Link: https://doi.org/10.2903/..
 
?
10

Correlation ofInVivoVersusIn VitroBenchmark Doses (BMDs) De..:

Soeteman-Hernández, Lya G. ; Fellows, Mick D. ; Johnson, George E..
Toxicological Sciences.  148 (2015)  2 - p. 355-367 , 2015
Link: https://doi.org/10.1093/..
 
?
11

Estimating the carcinogenic potency of chemicals from thein..:

Soeteman-Hernández, Lya G. ; Johnson, George E. ; Slob, Wout
Mutagenesis.  31 (2015)  3 - p. 347-358 , 2015
Link: https://doi.org/10.1093/..
 
?
12

Empirical analysis of BMD metrics in genetic toxicology par..:

Wills, John W. ; Johnson, George E. ; Doak, Shareen H....
Mutagenesis.  31 (2015)  3 - p. 255-263 , 2015
Link: https://doi.org/10.1093/..
 
?
13

New approaches to advance the use of genetic toxicology ana..:

Johnson, George E. ; Slob, Wout ; Doak, Shareen H....
Toxicology Research.  4 (2015)  3 - p. 667-676 , 2015
Link: https://doi.org/10.1039/..
 
?
14

Exploring the Uncertainties in Cancer Risk Assessment Using..:

Slob, Wout ; Bakker, Martine I. ; Biesebeek, Jan Dirk te.
Risk Analysis.  34 (2014)  8 - p. 1401-1422 , 2014
Link: https://doi.org/10.1111/..
 
?
15

Does EU legislation allow the use of the Benchmark dose (BM..:

Brandon, E.F.A. ; Bulder, A.S. ; van Engelen, J.G.M....
Regulatory Toxicology and Pharmacology.  67 (2013)  2 - p. 182-188 , 2013
Link: https://doi.org/10.1016/..
 
1-15